Tabbetha Dobbins

Director at Sentrimed.

Earliest Form D on file: May 2026

Filed May 13, 2026

Sentrimed

Oral podoplanin inhibitor for head and neck cancer

Biotech, Mullica Hill NJ

Named, Director.

$250K

sold of $1M offered

Network

At Sentrimed

7 people

William Ragatz
Executive Officer, Director, signed as Presidnet
Jack Goldberg
Executive Officer, Director
Mari Rhodehamel Yin
Executive Officer, Director
Arye Rosen
Executive Officer
Bradley Galer
Director
Christopher Leonard
Executive Officer

1 more at Sentrimed